The identification of cancer type-specific evolutionary signatures could be used for patient stratification. Here, the authors develop a method, ASCETIC, that utilises bulk and single-cell sequencing data and identifies evolutionary signatures associated with different prognostic outcomes across different cancer types.
- Diletta Fontana
- Ilaria Crespiatico
- Daniele Ramazzotti
